Register entry
- Registered sites
- 0
- Active NDC listings
- 21
- Labeller names
- 3
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
2121 active NDC listings: 21 human otc drug. By marketing category: ANDA 20, OTC MONOGRAPH FINAL 1.
| Dosage form | NDCs |
|---|---|
| tablet | 6 |
| aerosol, foam | 4 |
| capsule, delayed release | 3 |
| gel | 2 |
| tablet, delayed release | 2 |
| tablet, orally disintegrating | 2 |
| spray, metered | 1 |
| suppository | 1 |
| Route | NDCs |
|---|---|
| oral | 13 |
| topical | 6 |
| nasal | 1 |
| rectal | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| innovus pharmaceuticals, inc. | 10 |
| innovus pharmaceuticals, inc. | 10 |
| innovus pharmaceuticals inc. | 1 |
Catalogue
Marketed products
21| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Acid Reducer | Omeprazole | tablet, delayed release, oral | 57483-120ANDA |
| Allervarx | Loratadine | tablet, orally disintegrating, oral | 57483-950ANDA |
| Allervarx | Loratadine | tablet, orally disintegrating, oral | 57483-955ANDA |
| Cetirizine Hydrochloride (Allergy) | Cetirizine Hydrochloride | tablet, oral | 57483-190ANDA |
| Crcle Cetirizine Hydrochloride | Cetirizine Hydrochloride | tablet, oral | 57483-250ANDA |
| Crcle Diclofenac Sodium Topical Gel 1% | Diclofenac Sodium Topical Gel 1% | gel, topical | 57483-596ANDA |
| Crcle Fexofenadine Hydrochloride | Fexofenadine Hydrochloride | tablet, oral | 57483-230ANDA |
| Crcle Fexofenadine Hydrochloride | Fexofenadine Hydrochloride | tablet, oral | 57483-240ANDA |
| Crcle Guaifenesin Extended-Release Tablets, 600 mg | Guaifenesin Extended-Release | tablet, oral | 57483-270ANDA |
| Crcle Guaifensin Extended Release Tablet, 1200 mg | Guaifensin Extended-Release | tablet, oral | 57483-280ANDA |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM | gel, topical | 57483-185ANDA |
| Esomeprazole | esomeprazole magnesium | capsule, delayed release, oral | 57483-900ANDA |
| Esomeprazole Magnesium | Esomeprazole Magnesium | capsule, delayed release, oral | 57483-225ANDA |
| FLUTICARE | fluticasone propionate | spray, metered, nasal | 57483-180ANDA |
| REGOXIDINE (FOR MEN) | MINOXIDIL | aerosol, foam, topical | 57483-165ANDA |
| REGOXIDINE (FOR WOMEN) | MINOXIDIL | aerosol, foam, topical | 57483-175ANDA |
| Regoxidine (For Men) | Minoxidil | aerosol, foam, topical | 57483-530ANDA |
| Regoxidine (For Women) | Minoxidil | aerosol, foam, topical | 57483-540ANDA |
| Xyralid Hemorrhoidal | Hemorrhoidal Suppositories | suppository, rectal | 57483-410OTC MONOGRAPH FINAL |
| omeprazole | omeprazole | capsule, delayed release, oral | 57483-740ANDA |
| omeprazole | omeprazole | tablet, delayed release, oral | 57483-840ANDA |
Compare
Other companies listing cetirizine hydrochloride
- Cardinal Health 418, Inc.34 sites · 833 NDC
- Dr. Reddy's Laboratories Limited15 sites · 683 NDC
- Sun Pharmaceutical Industries Limited13 sites · 918 NDC
- Granules Pharmaceuticals Inc.8 sites · 302 NDC
- Piramal Healthcare (Canada) Limited8 sites · 86 NDC
- Kenvue Brands LLC7 sites · 564 NDC
- CIPLA PHARMACEUTICALS LIMITED7 sites · 368 NDC
- Aurobindo Pharma Limited6 sites · 1,453 NDC
- Sandoz Industrial Products S.A5 sites · 441 NDC
- International Medication Systems, Ltd.3 sites · 2,801 NDC
Enquiry
Common questions
- Is Innovus Pharmaceuticals, Inc. FDA approved?
- Innovus Pharmaceuticals, Inc. holds no registered establishment of its own; 21 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Innovus Pharmaceuticals, Inc. make?
- 21 products are listed under Innovus Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as tablet; aerosol, foam; capsule, delayed release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.